Bioexplorer
GLP-1 Apprentice
There seems to be a consensus here that tirzepitide is best for reducing inflammation with lots of anecdotal reports that this particular dual agonist provides better pain relief for various ailments than semaglutide or retatrutide. And several members have reported that they switched from Reta to Tirz specifically for this effect.
But it is generally accepted that hs-CRP is the best indicator of systemic inflammation so we have a non-subjective way to measure inflammation reduction already. 10mg Tirz gave a 34% reduction. EL reports substantial reduction in the Reta trials but I haven't seen any numbers. However, based on liver and kidney effects, many people expect a greater reduction in hs-CRP than Tirz.
Did I miss some data showing actual CRP numbers for Reta? Any insight on why Tirz could provide a better subjective effect on inflammation even though Reta probably has similar hs-CRP benefits?
But it is generally accepted that hs-CRP is the best indicator of systemic inflammation so we have a non-subjective way to measure inflammation reduction already. 10mg Tirz gave a 34% reduction. EL reports substantial reduction in the Reta trials but I haven't seen any numbers. However, based on liver and kidney effects, many people expect a greater reduction in hs-CRP than Tirz.
Did I miss some data showing actual CRP numbers for Reta? Any insight on why Tirz could provide a better subjective effect on inflammation even though Reta probably has similar hs-CRP benefits?